Antiamoebic chemoprophylaxis using quinfamide in children: a comparative study

Area of Science:

• Infectious Diseases
• Public Health
• Parasitology

Background:

• Entamoeba histolytica is a significant cause of amoebic infections.
• Controlling parasitic infections in school-aged children is crucial for public health.
• Evaluating chemoprophylaxis strategies is essential for managing endemic parasitic diseases.

Purpose of the Study:

• To assess the efficacy of quinfamide administered at 3- or 6-month intervals in reducing Entamoeba histolytica cyst frequency.
• To compare the effectiveness of different quinfamide treatment schedules against amoebic infections in children.
• To determine if antiamoebic chemoprophylaxis is a viable control measure in areas with poor hygiene.

Main Methods:

• A prospective, longitudinal, randomized, single-blind study involving 1,524 primary school children.
• Participants with confirmed Entamoeba histolytica cysts received quinfamide treatment.
• Stool samples were analyzed using parasitoscopic concentration (PSC) at various intervals (3, 6, 12 months) post-treatment.

Main Results:

• After 12 months, 37.6% of the annual treatment group (Group 1) remained positive for cysts.
• The 6-month interval group (Group 2) showed the lowest cyst prevalence at 12.5%.
• The 3-month interval group (Group 3) had 23.5% of subjects testing positive (p < 0.05 for Group 2 vs. Group 1 and Group 3 vs. Group 1).

Conclusions:

• Six-month interval quinfamide administration is more effective than annual treatment in controlling Entamoeba histolytica.
• Antiamoebic chemoprophylaxis can be an effective control strategy, particularly where hygiene and food safety are suboptimal.
• Regular, interval-based administration of quinfamide presents a promising approach to reduce amoebic infection burdens.